Argatroban in Critically Ill Patients With Heparin Resistance
NCT01734252
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Achievement of a Sufficient Thrombosis Prohpylaxis in Clitically Ill Patients With Heparin Resistance
Interventions
DRUG:
Argatroban
Sponsor
Medical University Innsbruck